Company Intelligence Profile

Rn Chidakashi Technologies Private Limited

Wysa is an AI chatbot app for everyday mental health and emotional wellbeing, built by RN Chidakashi Technologies.

CIN: U72900MH2015PTC261095ActiveRoC Maharashtra

Last updated 15 October 2026

AI OverviewGenerated from public records

RN Chidakashi Technologies Private Limited runs Wysa, an AI chatbot app for mental health and emotional wellbeing. The company was incorporated on 19 January 2015 and is registered in Mumbai, Maharashtra. It sells to consumers and to employers and health plans in the US, UK and India. Its latest funding round was a $20M Series B in July 2022.

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about RN Chidakashi Technologies

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Registered nameRN CHIDAKASHI TECHNOLOGIES PRIVATE LIMITED
CINU72900MH2015PTC261095
PANAAHCR1870M
StatusActive
ListingUnlisted
Incorporated19 January 2015
ROCRoC Maharashtra (Mumbai)
Sector (NIC)Healthcare (NIC 72900)
Registered addressFlat No. 4, Stambhtirth Bldg, Plot No. 82, R.A. Kidwai Road, Wadala, Mumbai City, Maharashtra 400031, India
Authorized capitalINR 90.0 Lakh
Paid-up capitalINR 41.7 Lakh

Business Overview

  • RN Chidakashi Technologies is the company behind Wysa, an AI chatbot app for mental health and emotional wellbeing.
  • It offers free self-help tools based on CBT and DBT, plus mindfulness and mood-tracking exercises.
  • Paid access to human coaching and therapy is also available.
  • It sells directly to consumers and to employers, health plans and health systems in the US, UK and India.
  • It was founded in 2015 by Jo Aggarwal and Ramakant Vempati.

Directors

NameDINRoleAppointed
Prashant Vyankatesh Iyengar07034472Director-
Sneh Rajkumar Vaswani07034564Director-
Chetan Naik09263971Nominee Director-
Sudhir Kumar Sethi00058105Nominee Director-
Ashish Wadhwani06620044Nominee Director-
Sunil Kumar Goyal02312181Nominee Director-

GST Registration

GSTINStatePANStatus
27AAHCR1870M1ZXMaharashtraAAHCR1870M-
29AAHCR1870M1ZTKarnatakaAAHCR1870M-

Funding

Series B, Jul 2022$20M led by HealthQuad and British International Investment
Pre-Series A, 20 Jun 2019$2M (~₹15 Cr) led by pi Ventures, with Kae Capital
Seed, 2017$1.3M from Kae Capital and angel investors
Total raised~$29.4M as of mid-2022

Competitors

Woebot Health
US AI mental-health chatbot
Slingshot AI
US AI mental-health app
Ebb by Headspace
AI companion from Headspace Health
Limbic
UK, clinical and NHS-focused
Youper
US consumer mental-health app
Noah AI
emerging AI mental-health challenger

Frequently Asked Questions

What does RN CHIDAKASHI TECHNOLOGIES PRIVATE LIMITED do?
It is the company behind Wysa, an AI chatbot app for mental health and emotional wellbeing. It offers free self-help tools and paid access to human coaching and therapy.
When was RN CHIDAKASHI TECHNOLOGIES PRIVATE LIMITED incorporated?
It was incorporated on 19 January 2015 and is registered with the RoC Maharashtra (Mumbai). It is an unlisted private limited company.
What is the CIN of RN CHIDAKASHI TECHNOLOGIES PRIVATE LIMITED?
The CIN is U72900MH2015PTC261095.
Where is RN CHIDAKASHI TECHNOLOGIES PRIVATE LIMITED registered?
The registered office is at Flat No. 4, Stambhtirth Bldg, Plot No. 82, R.A. Kidwai Road, Wadala, Mumbai, Maharashtra 400031.
How much funding has RN CHIDAKASHI TECHNOLOGIES PRIVATE LIMITED raised?
It has raised about $29.4M as of mid-2022, including a $20M Series B in July 2022 led by HealthQuad and British International Investment.

Recur Market

Which lenders fit a company like Rn Chidakashi Technologies Private Limited?

Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.

Similar Healthcare companies

More on Recur Club

Explore on Recur Club

More from Recur Club

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.